Interestingly, the HA receptor CD44 is highly expressed in the subpopulation of breast cancer cells with stem cell potential, and HA-coated particles could be used as a vehicle to reach such an aggressive population of cells. The gene discussed is CD44; the disease is breast carcinoma.